Sudden infant death from dilated cardiomyopathy with endocardial fibroelastosis

Takahashi, Shirushi; Kanetake, Jun; Moriya, Takuya; Funayama, Masato

doi:10.1016/j.legalmed.2008.03.001

Cited by 12 publications

(7 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Primary EFE in the original description is characterized by the presence of ventricular dilatation, diffuse fibrous endocardial thickening, upward displacement of the papillary muscles, and valve leaflets thickening ( 20 , 23 , 24 ). In terms of “outcome,” EFE is characterized by a very poor prognosis in pediatric patients ( 25 , 26 ).…”

Section: Discussionmentioning

confidence: 99%

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy

et al. 2017

View full text Add to dashboard Cite

BackgroundLittle is known about the clinical value of late gadolinium enhancement (LGE), in children affected by dilated cardiomyopathy (DCM).Materials and methodsWe retrospectively evaluated 15 patients (8 ± 6 years, 6 males) with diagnosis of DCM who underwent cardiac magnetic resonance since 2014. All scans were performed with a 1.5 T system (Aera, Siemens). Study protocol included cine steady-state free precession sequences, followed by administration of 0.2 mmol/kg of gadolinium-based contrast agent. Inversion recovery Turbo Flash sequences, in the same position of cine images, were acquired 10–15 min after the injection of contrast agent, in order to assess the presence of LGE. The latter was considered positive with a signal intensity >6 SD from normal myocardial tissue. Indexed end-diastolic volume (EDVi) and end-systolic volume (ESVi), and left ventricle (LV) ejection fraction (EF) were calculated by using dedicated software on off-line workstation. Global longitudinal strain and diastolic function were evaluated by echocardiography. Clinical follow-up, including death, transplant, and listing for heart transplant [major adverse cardiac events (MACE)], were evaluated. Patients were divided into two different subgroups: negative (Group A) and positive (Group B) for presence of LGE. Statistical analysis was performed by using Mann–Whitney U test (p < 0.05 considered as statistically significant).ResultsSeven patients (47%) showed LGE. A global diffuse subendocardial pattern was evident in all patients presenting LGE (7/7, 100%). The following main LV indexes were observed in the two subgroups. Group A: EDVi = 96 ± 33 ml, ESVi = 56 ± 29 ml, LV EF = 45 ± 10%, global longitudinal strain = −16 ± 5%, E/e′ ratio = 10 ± 3, MACE = 1. Group B: EDVi = 130 ± 60 ml, ESVi = 89 ± 43 ml, LV EF = 31 ± 6%, global longitudinal strain = −13 ± 4%, E/e′ ratio = 9 ± 3, MACE = 3. There was no statistically significant difference between the two groups, in terms of EDVi (p: 0.2), ESVi (p: 0.2), and E/e′ ratio (0.9), whereas a significant difference of LV EF, presence of significative mitral regurgitation, and global longitudinal strain were observed (respectively, p: 0.03, p: 0.009, and p: 0.03).ConclusionIn our population of children with DCM, LGE shows a global diffuse subendocardial pattern. Presence of LGE seems to play a role in these patients determining a worst global systolic function.

show abstract

Section: Discussionmentioning

confidence: 99%

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy

et al. 2017

View full text Add to dashboard Cite

show abstract

“…EFE is an adverse prognostic factor for children and adolescents with dilated cardiomyopathy 4). There have been many reports about EFE presenting in fetuses, infants and children including a Korean report, in which EFE was proved by autopsy after sudden unexpected death of the infant 5-7). There was a Korean paper about idiopathic restrictive cardiomyopathy in children, but the pathologic diagnosis was not investigated 8).…”

Section: Discussionmentioning

confidence: 99%

Endocardial Fibroelastosis in a 57-Year-Old Transplant Recipient

et al. 2010

View full text Add to dashboard Cite

Endocardial fibroelastosis (EFE) is characterized by deposition of collagen and elastin leading to ventricular hypertrophy and diffuse endocardial thickening. Here we report (for the first time in Korea) the case of a EFE presenting with heart failure. The patient was a 57-year-old woman who had complained of dyspnea on exertion {New York Heart Association (NYHA) functional class 3} and abdominal distension at the time of hospital admission. Echocardiography showed severe diastolic dysfunction with normal systolic function. On MRI, the contrast-enhanced delayed myocardial image demonstrated hyperenhancement in the endocardium. Owing to progressive heart failure, the patient was transplanted. Histological examination of the explanted heart showed irregularly thickened endocardium with fibrosis and elastosis in the both ventricles, compatible with the diagnosis of EFE.

show abstract

“…Clinical findings mainly include heart failure, pulmonary infection, exercise intolerance, shortness of breath, and prolonged breastfeeding time ( 4 ). Importantly, the onset of EFE is rapid and patients might have a poor prognosis or even die without timely treatment ( 5 , 6 ). Therefore, the diagnosis of EFE should be established early and accurately.…”

Section: Introductionmentioning

confidence: 99%

The value of cardiac magnetic resonance imaging in endocardial fibroelastosis

Xiao

Wang²,

Cheng³

et al. 2022

Front. Pediatr.

View full text Add to dashboard Cite

IntroductionEndocardial fibroelastosis (EFE), an uncommon congenital heart disorder often occurring in infants, has a poor prognosis. It is of great significance to perform early diagnosis and accurately analyze cardiac function to enable further clinical treatment and prognosis decisions. This study aimed to explore the findings of cardiac magnetic resonance (CMR) in patients with EFE, including morphological changes and cardiac function analyses. Additionally, we compared the difference in the evaluation of the cardiac function between CMR and echocardiography (Echo).MethodsEleven patients with EFE (nine females and two males, aged between 0.3 and 1.9 years), treated in our hospital, were analyzed retrospectively. Left ventricular posterior wall thickness (LVPW), anterior wall thickness (LVAW), fractional shortening (FS), ejection fraction (EF), end-systolic diameter (ESD), end-diastolic diameter (EDD), end-systolic volume (ESV), and end-diastolic volume (EDV) were assessed using both Echo and CMR. The Original Ross classification and the New York Heart Association functional classification were used to grade the patients’ cardiac function. The correlations between clinical cardiac function classification and MRI- and Echo-derived imaging data were determined.ResultsAll patients showed a thickened endocardium and left ventricle globular dilatation on CMR. We observed significant systolic dysfunction and whole or segmental abnormal ventricular movement. Compared with those measured by Echo, the EF, FS, and EDV values were significantly lower when measured using CMR. Compared with Echo measurements, the ESV, ESD, LVAW, and LVPW values were significantly higher when measured using CMR. CMR-measured EF and FS correlated better with the clinical cardiac functional score than those derived from Echo (EF, r = 0.646 > 0.224; FS, r = 0.627 > 0.245, respectively).ConclusionIn patients with EFE, the characteristic morphological changes of the heart could be displayed accurately using CMR. The parameters measured by CMR were more accurate than those of Echo and correlated well with clinical cardiac function scores, mainly because it does not make invalid geometrical assumptions.

show abstract

Sudden infant death from dilated cardiomyopathy with endocardial fibroelastosis

Cited by 12 publications

References 15 publications

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy

Endocardial Fibroelastosis in a 57-Year-Old Transplant Recipient

The value of cardiac magnetic resonance imaging in endocardial fibroelastosis

Contact Info

Product

Resources

About